Skip to main content

U.K. stocks climb on EU recovery deal and vaccine hopes but AstraZeneca falls

U.K. stocks advanced on Tuesday, as investors cheered the European Union’s €750 billion coronavirus recovery plan and positive vaccine developments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.